Circassia Achieves Positive Phase II Clinical Results With Ragweed Allergy T-Cell Vaccine

Saturday, February 13th, 2010

Circassia Ltd, a specialty biopharmaceutical company focused on allergy, announced that its ToleroMune(R) ragweed allergy T-cell vaccine achieved positive results in a recently completed phase II clinical trial. Ragweed allergy is particularly common in America, where it affects approximately 25% of the population. Circassia's latest clinical results follow ...

Posted in Healthy LifeStyle | No Comments »

H1N1: Many Parents, High-Priority Adults Unable To Get Vaccine

Saturday, November 7th, 2009

A new national poll from Harvard School of Public Health (HSPH) researchers found that a majority of adults who tried to get the H1N1 vaccine for themselves or their children have been unable to do so. The poll, which examines the American public's response to the H1N1 vaccine ...

Posted in Healthy LifeStyle | No Comments »